ArticleCureus2025
Maturity-Onset Diabetes of the Young (MODY) Presenting With a Diabetic Foot Ulcer: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maturity-onset diabetes of the young (MODY) is a rare form of diabetes that accounts for a minority of all reported cases of diabetes. Unlike the more common forms of diabetes, MODY typically presents in adolescents or young adults, usually before the age of 25. It is characterized by autosomal dominant inheritance and results from gene mutations involved in pancreatic beta-cell function. To date, 14 genetic subtypes have been identified, each with slightly different presentations and differing in their response to standardized treatment. In this report, we highlight a case of a young female presenting with clinical features usually seen in chronic cases of type 2 diabetes mellitus, such as non-healing wounds on her foot, but who reported no other symptoms typically seen in diabetics. She was found to have raised fasting blood glucose levels on presentation as well as a strong family history of diabetes (early-onset diabetes in a first-degree relative). Upon testing, her glycated hemoglobin (HbA1c) level was also found to be 14.6% (the normal range for the HbA1c level is usually considered to be below 5.7%). The patient was later advised to undergo anti-GAD65 antibody testing, and a fasting C-peptide level was obtained to evaluate endogenous insulin production. Both tests returned within normal limits, suggesting preserved beta-cell function. Given this history and atypical presentation, MODY was suspected. This case underscores the importance of considering MODY in young diabetic patients with significant family histories, as early genetic confirmation and personalized management can improve disease outcomes and lead to family screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.